![]() IM156 structure
|
Common Name | IM156 | ||
---|---|---|---|---|
CAS Number | 1422365-93-2 | Molecular Weight | 315.29 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 337.2±52.0 °C at 760 mmHg | |
Molecular Formula | C13H16F3N5O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 157.8±30.7 °C |
Use of IM156Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat also suppresses B-cell activation to alleviate systemic lupus erythematosus[1][5]. |
Name | N-{N-[4-(Trifluoromethoxy)phenyl]carbamimidoyl}-1-pyrrolidinecarboximidamide |
---|---|
Synonym | More Synonyms |
Description | Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat also suppresses B-cell activation to alleviate systemic lupus erythematosus[1][5]. |
---|---|
Related Catalog | |
Target |
oxidative phosphorylation (OXPHOS)[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 337.2±52.0 °C at 760 mmHg |
Molecular Formula | C13H16F3N5O |
Molecular Weight | 315.29 |
Flash Point | 157.8±30.7 °C |
Exact Mass | 315.130707 |
LogP | 0.96 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.578 |
Hazard Codes | Xn |
---|
N-{N-[4-(Trifluoromethoxy)phenyl]carbamimidoyl}-1-pyrrolidinecarboximidamide |
1-Pyrrolidinecarboximidamide, N-[imino[[4-(trifluoromethoxy)phenyl]amino]methyl]- |